logo for Bristol-Myers Squibb

Bristol-Myers Squibb

Manufacturing · New Jersey, United States · 34,100 Employees

View Company Info for Free

About

Headquarters

Route 206 & Province Line Princeton Rd, Princet...

Phone Number

(800) 332-2056

Revenue

$45.5 Billion

Stock Symbol

BMY

Industry

Pharmaceuticals Healthcare

Highlights

$4B

Total Funding Amount

$4B

Most Recent Funding Amount

3

Number of Funding Rounds

Who is Bristol-Myers Squibb

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, and distributes biopharmaceutical products worldwide. The compan y offers chemically-synthesized drug and biologic in various therapeutic areas, such as oncology; cardiovascular; immunoscience; and virology comprising human immunodeficiency virus infection (HIV). Its products include Empliciti, a humanized monoclonal antibody to treat multiple myeloma; Opdivo, a human monoclonal antibody to treat renal cell carcinoma, non-small cell lung cancer, classical Hodgkin lymphoma, gastric cancer, melanoma, metastatic urothelial carcinoma, and squamous cell carcinoma of the head and neck; Erbitux, an IgG1 monoclonal antibody that blocks the epidermal growth factor receptor; Sprycel, a tyrosine kinase inhibitor for the treatment of adults with Philadelphia chromosome-positive chronic myeloid leukemia; and Yervoy, a monoclonal antibody for metastatic melanoma. The companys products also comprise Eliquis, an oral factor Xa inhibitor targeted at stroke prevention in atrial fibrillation; Baraclude to treat chronic hepatitis B virus; Daklinza and Sunvepra to treat hepatitis C virus (HCV); Reyataz and Sustiva to treat HIV; Abilify, an antipsychotic agent for adults with schizophrenia, bipolar mania disorder, and depressive disorder; Beclabuvir, a non-nucleoside NS5B inhibitor for the treatment of HCV; and Orencia to treat rheumatoid arthritis. It has collaboration agreements with Portola Pharmaceuticals, Inc., Apexigen, Inc., and Nordic Bioscience; clinical research collaborations with Array BioPharma, Novartis, Clovis Oncology, Inc., and Daiichi Sankyo; and license agreement with Nitto Denko Corporation to develop and commercialize siRNA molecules targeted at HSP47 in vitamin A. The company was formerly known as Bristol-Myers Company and changed its name to Bristol-Myers Squibb Company in 1989. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York.Read more

Bristol-Myers Squibb's Social MediaPopular SearchesBristol-Myers SquibbBristol-myers Squibb CoCelgene CorpBristol Myers SquibbBristol - Myers Squibb CoSIC Code 28,283NAICS Code 32,325Ticker NYSE: BMYShow more

Bristol-Myers Squibb Org Chart

PhoneEmail
Ann Powell

Executive VP & Global Chief Human Resources O...

PhoneEmail
Ann Judge

Senior VP & Chief Human Resources Officer

PhoneEmail

PhoneEmail

Is Bristol-Myers Squibb your ideal costumer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Similar Companies to Bristol-Myers Squibb

  1. 88,000
    $54.9B

    1

  2. 70,212
    $39B

    2

  3. 11,076
    $7.4B

    3

  4. 50,000
    $54.4B

    4

  5. 89,900
    $47.6B

    5

  6. 70,000
    $61.4B

    6

See more similar companies

Compare CEO

How does Giovanni Caforio compare against Competing Companies' CEOs?

Giovanni Caforio

Giovanni Caforio

CEO at Bristol-Myers Squibb

Top 10%

CEO effectiveness to drive business results

Excellent
25%
Good
75%
Average
0%
Poor
0%
Very Bad
0%
CEO management style
Good
71%
Bad
28%

VS.

Joaquin Duato
Top 15%

CEO effectiveness to drive business results

Excellent
25%
Good
0%
Average
50%
Poor
12%
Very Bad
12%
CEO management style
Good
75%
Bad
25%
Select a different CEO to compare
Joaquin Duato

Joaquin Duato

CEO at Johnson & Johnson

Rob Davis

Rob Davis

CEO at Merck

Albert Bourla

Albert Bourla

CEO at Pfizer

Pascal Soriot

Pascal Soriot

CEO at AstraZeneca

Bristol-Myers Squibb Email Formats

Bristol-Myers Squibb uses at least 5 email formats with first.last (ex. John.Smith@bms.com) being used 88.4% of the time

Bristol-Myers Squibb Email FormatsPercentage

Get Verified Emails

View Email Formats for Bristol-Myers Squibb

Bristol-Myers Squibb Company Metrics

Company Insights
Employee Growth Rate
Funding
Funding DateNov 06, 2020
RoundDebt
Amount$4B
InvestorsCiti, JPMorgan Chase
Funding DateMay 08, 2019
RoundDebt
Amount$19M
InvestorsUndisclosed
Funding DateFeb 23, 2017
RoundPrivate Equity
Amount-
InvestorsCarl Icahn
See More

$4B

Total Funding Amount

$4B

Most Recent Funding Amount

3

Number of Funding Rounds

Acquisitions & Subsidiaries

Jul 18, 2022

Celgene

Jul 18, 2022

Juno Therapeutics

Nov 04, 2020

RayzeBio

Mar 19, 2019

Karuna Therapeutics

Jul 27, 2017

iZumi Bio

Jan 11, 2014

Turning Point Therapeutics

See More Acquisitions & Subsidiaries

Bristol-Myers Squibb Tech Stack

A closer look at the technologies used by Bristol-Myers Squibb

Top Companies in United States

Top 10 companies in United States by revenue

Top 10 companies in United States by number of employees

Top 10 companies in United States by total funding amount

See top companies

Most Recent Scoops

Jul 22 2024
Left Company
Executive Moves, Left Company
Jun 20 2024
Left Company
Executive Move
Executive Moves, Left Company
Jun 18 2024
Left Company
Executive Moves, Left Company
Jun 5 2024
Project
Spending/Investment
Jun 5 2024
Open Position
Executive Move
Bristol-Myers Squibb is currently seeking a new Senior Vice President & Chief Quality Officer.
Executive Moves, Seeking Replacement
See more scoops

Bristol-Myers Squibb News & Media

Read more news

Frequently Asked Questions regarding Bristol-Myers Squibb

Where is Bristol-Myers Squibb located?
Bristol-Myers Squibb's headquarters are located at Route 206 & Province Line Princeton Rd, Princeton, New Jersey, 08543, United States
What is Bristol-Myers Squibb's phone number?
Bristol-Myers Squibb's phone number is (800) 332-2056
What is Bristol-Myers Squibb's stock symbol?
Bristol-Myers Squibb's stock symbol is BMY
What is Bristol-Myers Squibb's official website?
Bristol-Myers Squibb's official website is www.bms.com
What is Bristol-Myers Squibb's Revenue?
Bristol-Myers Squibb's revenue is $45.5 Billion
What is Bristol-Myers Squibb's SIC code?
Bristol-Myers Squibb's SIC: 28,283
What is Bristol-Myers Squibb's NAICS code?
Bristol-Myers Squibb's NAICS: 32,325
How many employees does Bristol-Myers Squibb have?
Bristol-Myers Squibb has 34,100 employees
What industry does Bristol-Myers Squibb belong to?
Bristol-Myers Squibb is in the industry of: Pharmaceuticals, Healthcare
What is Bristol-Myers Squibb competition?
Bristol-Myers Squibb top competitors include: Pfizer, GSK, Eisai, AbbVie
What companies has Bristol-Myers Squibb acquired?
Bristol-Myers Squibb has acquired the companies: Celgene, Juno Therapeutics, RayzeBio, Karuna Therapeutics
What technology does Bristol-Myers Squibb use?
Some of the popular technologies that Bristol-Myers Squibb uses are: Qualtrics Site Intercept, EventPro, Microsoft IIS, SAP Sybase RAP
How do I contact Bristol-Myers Squibb?
Bristol-Myers Squibb contact info: Phone number: (800) 332-2056 Website: www.bms.com
What does Bristol-Myers Squibb do?

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, and distributes biopharmaceutical products worldwide. The company offers chemically-synthesized drug and biologic in various therapeutic areas, such as oncology; cardiovascular; immunoscience; and virology comprising human immunodeficiency virus infection (HIV). Its... products include Empliciti, a humanized monoclonal antibody to treat multiple myeloma; Opdivo, a human monoclonal antibody to treat renal cell carcinoma, non-small cell lung cancer, classical Hodgkin lymphoma, gastric cancer, melanoma, metastatic urothelial carcinoma, and squamous cell carcinoma of the head and neck; Erbitux, an IgG1 monoclonal antibody that blocks the epidermal growth factor receptor; Sprycel, a tyrosine kinase inhibitor for the treatment of adults with Philadelphia chromosome-positive chronic myeloid leukemia; and Yervoy, a monoclonal antibody for metastatic melanoma. The companys products also comprise Eliquis, an oral factor Xa inhibitor targeted at stroke prevention in atrial fibrillation; Baraclude to treat chronic hepatitis B virus; Daklinza and Sunvepra to treat hepatitis C virus (HCV); Reyataz and Sustiva to treat HIV; Abilify, an antipsychotic agent for adults with schizophrenia, bipolar mania disorder, and depressive disorder; Beclabuvir, a non-nucleoside NS5B inhibitor for the treatment of HCV; and Orencia to treat rheumatoid arthritis. It has collaboration agreements with Portola Pharmaceuticals, Inc., Apexigen, Inc., and Nordic Bioscience; clinical research collaborations with Array BioPharma, Novartis, Clovis Oncology, Inc., and Daiichi Sankyo; and license agreement with Nitto Denko Corporation to develop and commercialize siRNA molecules targeted at HSP47 in vitamin A. The company was formerly known as Bristol-Myers Company and changed its name to Bristol-Myers Squibb Company in 1989. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York.Read More

What are Bristol-Myers Squibb social media links?
Bristol-Myers Squibb Linkedin page Bristol-Myers Squibb Twitter page Bristol-Myers Squibb Facebook page
How much funding has Bristol-Myers Squibb raised to date?
Bristol-Myers Squibb has raised $4 Billion in 3 funding rounds
When was the last funding round for Bristol-Myers Squibb?
Bristol-Myers Squibb closed its last funding round on Nov 06, 2020 with the amount of $4 Billion
Who invested in Bristol-Myers Squibb?
Bristol-Myers Squibb has 4 investors including Citi, JPMorgan Chase, Undisclosed and Carl Icahn.
Is Bristol-Myers Squibb a public company?
Yes, Bristol-Myers Squibb is a public company and is traded under the symbol BMY
See more information about Bristol-Myers Squibb

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.